Keymed Biosciences Inc.
HKEX:2162.HK
31.75 (HKD) • At close December 24, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||||||||
| Nettowinst
| -168.373 | -168.373 | -203.162 | -203.162 | 23.484 | 23.484 | -156.785 | -156.785 | 2.727 | 2.727 | -129.405 | -129.405 | -1,814.25 | -1,814.25 | -391.549 | -391.549 | -17.743 | -17.743 |
| Afschrijvingen & Amortisatie
| 23.168 | 23.168 | 21.178 | 21.082 | 13.306 | 13.306 | 10.518 | 10.518 | 7.376 | 7.376 | 5.24 | 5.24 | 5.231 | 5.231 | 5.252 | 5.252 | 4.235 | 4.235 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | -96.84 | 14.277 | -61.038 | -9.424 | -2.799 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 8.817 | 8.817 | 12.198 | 12.198 | 7.842 | 7.842 | 12.686 | 12.686 | 11.598 | 11.598 | 8.657 | 8.657 | 49.755 | 49.755 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -29.206 | -29.206 | 7.719 | 7.719 | -3.794 | -3.794 | 43.345 | 43.345 | -52.244 | -52.244 | 18.926 | 18.926 | -13.695 | -13.695 | 18.966 | 18.966 | -24.179 | -24.179 |
| Vorderingen
| 7.147 | 7.147 | -9.395 | -9.395 | -4.151 | -4.151 | -0.34 | 0 | 1.99 | 1.99 | -1.99 | -1.99 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| -13.788 | -13.788 | 12.039 | 12.039 | -17.968 | -17.968 | -3.262 | -3.262 | -10.789 | -10.789 | 2.075 | 2.075 | -6.849 | -6.849 | -0.169 | -0.169 | -1.601 | -1.601 |
| Crediteuren
| 0 | 0 | 0 | 0 | 21.662 | 0 | 5.087 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -22.564 | -22.564 | 5.075 | 5.075 | 18.325 | 18.325 | 46.607 | 46.607 | -43.445 | -43.445 | 18.841 | 18.841 | -6.847 | -6.847 | 19.135 | 19.135 | -22.578 | -22.578 |
| Overige Niet-Contante Posten
| -17.368 | -17.368 | -9.564 | -9.467 | -21.017 | -21.017 | -28.041 | -28.041 | -52.146 | -52.146 | 31.639 | 31.639 | 1,730.584 | 1,730.584 | 347.559 | 347.559 | -2.221 | -2.221 |
| Kasstroom uit Operationele Activiteiten
| -182.961 | -182.961 | -171.631 | -171.631 | 19.821 | 19.821 | -118.278 | -118.278 | -82.689 | -82.689 | -64.944 | -64.944 | -42.375 | -42.375 | -19.773 | -19.773 | -39.908 | -39.908 |
| Investeringsactiviteiten: | ||||||||||||||||||
| Investeringen in Materiële Vaste Activa
| -53.713 | -53.713 | -38.657 | -38.657 | -124.941 | -124.941 | -46.044 | -46.044 | -93.367 | -93.367 | -78.43 | -78.43 | -7.464 | -7.464 | -5.502 | -5.502 | -4.401 | -4.401 |
| Netto Overnames
| 0 | 0 | 0 | 0 | -170.32 | 0 | 79.145 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | -705.268 | 0 | -5,614.491 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 1,503.105 | 0 | 5,271.544 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 33.783 | 33.783 | 50.608 | 50.608 | 347.091 | 347.091 | -105.194 | -105.194 | -78.189 | -78.189 | -919.055 | -919.055 | -12.992 | -12.992 | 52.452 | 52.452 | -99.083 | -99.083 |
| Kasstroom uit Investeringsactiviteiten
| -19.93 | -19.93 | 11.952 | 11.952 | 222.15 | 222.15 | -151.237 | -151.237 | -171.556 | -171.556 | -997.485 | -997.485 | -20.455 | -20.455 | 46.95 | 46.95 | -103.484 | -103.484 |
| Financieringsactiviteiten: | ||||||||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | -34.238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -16.213 | -16.213 | -2.074 | -2.074 | -14.377 | -14.377 | -6.265 | -6.265 | -19.303 | -19.303 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 148.175 | 148.175 | 40.103 | 40.103 | 12.414 | 12.414 | -29.933 | -29.933 | 51.471 | 51.471 | 1,436.598 | 1,436.598 | 382.591 | 382.591 | -1.91 | -1.91 | 5.609 | 5.609 |
| Kasstroom uit Financieringsactiviteiten
| 131.962 | 131.962 | 38.029 | 38.029 | -1.964 | -1.964 | -36.198 | -36.198 | 32.168 | 32.168 | 1,436.598 | 1,436.598 | 382.591 | 382.591 | -1.91 | -1.91 | 5.609 | 5.609 |
| Overige Informatie: | ||||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.37 | 0.37 | -10.433 | -10.433 | 15.555 | 15.555 | 19.669 | 19.669 | 49.846 | 49.846 | -30.665 | -30.665 | -2.661 | -2.661 | -7.132 | -7.132 | 3.048 | 3.048 |
| Netto Kasstroomverandering
| -70.559 | -70.559 | -132.083 | -132.083 | 524.881 | 255.563 | -700.459 | -286.044 | -172.231 | -172.231 | 343.505 | 343.505 | 317.1 | 317.1 | 18.136 | 18.136 | -134.735 | -134.735 |
| Kaspositie aan het Einde van de Periode
| -70.559 | -70.559 | -132.083 | -132.083 | 1,203.094 | 255.563 | 678.213 | 890.114 | 1,176.157 | -172.231 | 343.505 | 1,177.114 | 833.609 | 317.1 | 18.136 | 181.274 | 163.138 | -134.735 |